2022
DOI: 10.3390/jcm11092534
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound-Guided Tru-Cut Biopsy in Gynecological and Non-Gynecological Pelvic Masses: A Single-Center Experience

Abstract: Aim: The aim of this study was to evaluate the feasibility of adequacy, accuracy, and safety of ultrasound-guided tru-cut biopsy in managing malignant and benign abdominopelvic masses in a selected population and critically discuss some issues in different situations, which deserve some reflections on those practices. Materials and Methods: This is a retrospective study involving 42 patients who underwent transvaginal or transabdominal tru-cut biopsy between August 2017 and November 2021. The inclusion criteri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 38 publications
0
0
0
Order By: Relevance
“…5,6 On the other hand, ultrasound-guided biopsy methods, with flexibility to use transabdominal, transvaginal, and transrectal approaches offer benefits and have minimal risk of complications, high accessibility and low costs, compared to computer tomography (CT) or magnetic resonance (MR) guidance. [7][8][9] The role of tru-cut biopsy in gynecological oncology has been addressed by several authors. 2,[10][11][12] In patients with poor performance status, with suspicion of recurrent disease, when surgery is not the first option of treatment, or when general anesthesia has to be avoided, the tru-cut biopsy is a less invasive option than laparoscopy.…”
Section: Introductionmentioning
confidence: 99%
“…5,6 On the other hand, ultrasound-guided biopsy methods, with flexibility to use transabdominal, transvaginal, and transrectal approaches offer benefits and have minimal risk of complications, high accessibility and low costs, compared to computer tomography (CT) or magnetic resonance (MR) guidance. [7][8][9] The role of tru-cut biopsy in gynecological oncology has been addressed by several authors. 2,[10][11][12] In patients with poor performance status, with suspicion of recurrent disease, when surgery is not the first option of treatment, or when general anesthesia has to be avoided, the tru-cut biopsy is a less invasive option than laparoscopy.…”
Section: Introductionmentioning
confidence: 99%